Novo Nordisk
David Rodríguez is a Principal Modelling Scientist at Novo Nordisk with a background in Computational Chemistry, specializing in Structure-Based Drug Design for CNS diseases. Prior to their current role, David held positions at Lundbeck and other research institutions focusing on GPCR families, drug discovery, and bioinformatics. David has a PhD in Molecular Medicine and a strong academic background in biochemistry and molecular research.
This person is not in any teams